Fungemia: Clinical Trials

6 trials for Fungemia, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

6 completed. 6 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable6Completed 6

Follow Fungemia: new trials by email Literature Review of Fungemia trials Research Report on Fungemia

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Candida PCR Diagnosis Strategy in Patients From Intensive Care Units
Diagnosis strategy based on C. glabrata / krusei PCR - Candida
Not applicableCompletedUniversity Hospital, Toulouse482022-05-192026-08-11
Clinical and Medico-economic Evaluation of a Rapid Test (ePlex-BCID®, GenMark) for the Diagnosis of Bacteremia and Fungemia.
Multiplex PCR, Current strategy alone - Bacteremia Sepsis, Fungemia
Not applicableCompletedUniversity Hospital, Grenoble3122019-06-202021-11-03
Non-Conventional Microbiological Methods in the Diagnosis of Candidemia
Candida Diagnostic Testing Panel - Candidemia, Invasive Candidiasis
Not applicableCompletedInstitute of Oncology Ljubljana22015-01-012026-02-19
Rapid Identification and Susceptibility Testing of Pathogens From Blood Cultures
FilmArray testing, Antimicrobial Stewardship, Bacterial culture - Bacteremia, Fungemia
Not applicableCompletedMayo Clinic7432013-08-012016-03-15
β-D-Glucan (BDG) Surveillance With Preemptive Anidulafungin vs. Standard Care for Invasive Candidiasis in Surgical Intensive Care Unit (SICU) Patients
Preemptive Therapy with Anidulafungin, Empiric antifungal therapy based on physician discretion. - Invasive Candidiasis
Not applicableCompletedDuke University642008-06-012015-02-06
Safety and Efficacy of Veronate® Versus Placebo in Preventing Nosocomial Staphylococcal Sepsis in Premature Infants
Veronate - Nosocomial Infections, Sepsis
Not applicableCompletedBristol-Myers Squibb20002004-05-012012-08-02

Narrower conditions

Candidemia (4)  ·  Candidiasis, Invasive (2)  ·  Sepsis (2)  ·  Torulopsis (2)  ·  Bacteremia (1)  ·  Cross Infection (1)  ·  Disease Susceptibility (1)  ·  Premature Birth (1)  ·  Staphylococcal Infections (1)

Broader conditions

Bacterial Infections and Mycoses (6)  ·  Infections (6)  ·  Inflammation (6)  ·  Invasive Fungal Infections (6)  ·  Mycoses (6)  ·  Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Systemic Inflammatory Response Syndrome (6)  ·  Candidiasis (4)  ·  Sepsis (4)  ·  Bacterial Infections (2)  ·  Candidiasis, Invasive (2)  ·  Disease Attributes (2)  ·  Female Urogenital Diseases and Pregnancy Complications (1)

Interventions

Anidulafungin (1)  ·  Antimicrobial Stewardship (1)  ·  Veronate (1)

Sponsors

Bristol-Myers Squibb (1)  ·  Duke University (1)  ·  Institute of Oncology Ljubljana (1)  ·  Mayo Clinic (1)  ·  University Hospital, Grenoble (1)  ·  University Hospital, Toulouse (1)

Countries

United States (3)  ·  France (2)  ·  Canada (1)  ·  Slovenia (1)

Top investigators

Barbara D Alexander, MD (1)  ·  John Perfect, MD (1)  ·  Kimberly E Hanson, MD (1)  ·  Ritu Banerjee, MD, Ph.D (1)  ·  Robin Patel, MD (1)  ·  Seth V. Hetherington, MD (1)

Results publications

PMID 17719934, PMID 22879929, PMID 26197846

NIH funding

KL2TR000136 (1), UM1AI104681 (1)